{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:18:44Z","timestamp":1791101924220,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bcp.2012.05.020","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T00:57:58Z","timestamp":1339203478000},"page":"459-467","source":"Crossref","is-referenced-by-count":34,"title":["Characterization of virus strains resistant to the herpes virus helicase\u2013primase inhibitor ASP2151 (Amenamevir)"],"prefix":"10.1016","volume":"84","author":[{"given":"Koji","family":"Chono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomitsu","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kontani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiyasu","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.05.020_bib0005","series-title":"Fields virology","first-page":"2479","article-title":"The family Herpesviridae: a brief introduction","author":"Pellet","year":"2007"},{"key":"10.1016\/j.bcp.2012.05.020_bib0010","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2012.05.020_bib0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2007.06.027","article-title":"Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management","volume":"57","author":"Fatahzadeh","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0020","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/0006-2952(82)90305-7","article-title":"Phosphorylation of acyclovir diphosphate by cellular enzymes","volume":"31","author":"Miller","year":"1982","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0025","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1016\/S0021-9258(20)79686-9","article-title":"Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase","volume":"255","author":"Miller","year":"1980","journal-title":"J Biol Chem"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2012.05.020_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jmv.1890410503","article-title":"Acyclovir: discovery, mechanism of action, and selectivity","author":"Elion","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/AAC.18.3.443","article-title":"In vitro susceptibility of varicella-zoster virus to acyclovir","volume":"18","author":"Biron","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0040","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1073\/pnas.74.12.5716","article-title":"Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine","volume":"74","author":"Elion","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.05.020_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0050","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1073\/pnas.77.4.2265","article-title":"Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1","volume":"77","author":"Coen","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.05.020_bib0055","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/AAC.29.5.894","article-title":"Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir","volume":"29","author":"Larder","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0163-7258(89)90097-1","article-title":"Antiviral effects of phosphonoformate (PFA, foscarnet sodium)","volume":"40","author":"Oberg","year":"1989","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2012.05.020_bib0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/135965350400900413","article-title":"Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients","volume":"9","author":"Str\u00e1nsk\u00e1","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bcp.2012.05.020_bib0075","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1093\/nar\/16.14.6585","article-title":"A DNA helicase induced by herpes simplex virus type 1","volume":"16","author":"Crute","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2012.05.020_bib0080","doi-asserted-by":"crossref","first-page":"20835","DOI":"10.1016\/S0021-9258(19)30008-0","article-title":"Overexpression and assembly of the herpes simplex virus type 1 helicase\u2013primase in insect cells","volume":"264","author":"Dodson","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.05.020_bib0085","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.86.7.2186","article-title":"Herpes simplex virus 1 helicase\u2013primase: a complex of three herpes-encoded gene products","volume":"86","author":"Crute","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.05.020_bib0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0402-386","article-title":"Herpes simplex virus helicase\u2013primase inhibitors are active in animal models of human disease","volume":"8","author":"Crute","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2012.05.020_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/095632020401500303","article-title":"Helicase primase: targeting the Achilles heel of herpes simplex viruses","volume":"15","author":"Kleymann","year":"2004","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drup.2010.11.002","article-title":"Antiviral drug resistance and helicase\u2013primase inhibitors of herpes simplex virus","volume":"14","author":"Field","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bcp.2012.05.020_bib0105","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/jac\/dkq198","article-title":"ASP2151, a novel helicase\u2013primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2","volume":"65","author":"Chono","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm0402-392","article-title":"New helicase\u2013primase inhibitors as drug candidates for the treatment of herpes simplex disease","volume":"8","author":"Kleymann","year":"2002","journal-title":"Nat Med"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2012.05.020_bib0115","first-page":"45","article-title":"Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity","volume":"14","author":"Levin","year":"2007","journal-title":"Herpes"},{"key":"10.1016\/j.bcp.2012.05.020_bib0120","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1099\/vir.0.011221-0","article-title":"A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure","volume":"90","author":"Biswas","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2010.04.008","article-title":"Effects of therapy using a helicase\u2013primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant","volume":"87","author":"Sukla","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bcp.2012.05.020_bib0130","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jac\/dkq135","article-title":"Mismatch primer-based PCR reveals that helicase\u2013primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor","volume":"65","author":"Sukla","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0135","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00705-007-0964-7","article-title":"Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase\u2013primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture","volume":"152","author":"Biswas","year":"2007","journal-title":"Arch Virol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2008.04.005","article-title":"Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase\u2013primase inhibitors, variously affect virus growth rate and pathogenicity","volume":"80","author":"Biswas","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bcp.2012.05.020_bib0145","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/jac\/dkn057","article-title":"A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase\u2013primase inhibitors in their mode of interaction with the antiviral target","volume":"61","author":"Biswas","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/AAC.17.2.209","article-title":"Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo","volume":"17","author":"Field","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2012.05.020_bib0155","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/jmv.20990","article-title":"Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient\/temperature-sensitive virus","volume":"79","author":"Shimada","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198902023200506","article-title":"Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome","volume":"320","author":"Erlich","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2012.05.020_bib0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JCM.42.1.242-249.2004","article-title":"Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up","volume":"42","author":"Danve-Szatanek","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jmv.10175","article-title":"Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus","volume":"68","author":"Saijo","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2004.04.002","article-title":"Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization","volume":"32","author":"Str\u00e1nsk\u00e1","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bcp.2012.05.020_bib0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2011.11.015","article-title":"Efficacy of ASP2151, a helicase\u2013primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo","volume":"93","author":"Himaki","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bcp.2012.05.020_bib0185","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JCM.39.3.913-917.2001","article-title":"Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates","volume":"39","author":"Shin","year":"2001","journal-title":"J Clin Microbiol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212003954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212003954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T03:26:14Z","timestamp":1687490774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212003954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0006295212003954"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.05.020","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}